Updated Jul 16, 2026
CHAUDHURI BHASKAR has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Bhaskar Chaudhuri is a corporate governance professional who, as of the most recent SEC filing dated 2026-06-16, serves as a director of Tarsus Pharmaceuticals, Inc., a biotechnology company. The SEC filing context confirms a board-director role with Tarsus, but public biographical details (education, career history, and other affiliations) are not provided in the context given. Given the commonality of the name, identity verification should rely on official filing records; there is no evidence in the provided context indicating death.
| Role | Director |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | TARS | Tarsus Pharmaceuticals, Inc. | M — Option exercise | 3.0K | — |
Bhaskar Chaudhuri is a corporate governance professional who, as of the most recent SEC filing dated 2026-06-16, serves as a director of Tarsus Pharmaceuticals, Inc., a biotechnology company. The SEC filing context confirms a board-director role with Tarsus, but public biographical details (education, career history, and other affiliations) are not provided in the context given…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CHAUDHURI BHASKAR profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.